US FDA takes step to change peptide compounding policy
Oct 15 (Reuters) — The US FDA on Thursday submitted a new policy change that could allow pharmacies to more easily compound certain peptides to the White House for consideration. Telehealth company Hims & Hers Health had previously said it plans to offer peptides if regulations permit. Advisers had recommended the US F